Bone Marrow TransplantationTransplantation, HomologousBone MarrowTransplantation, AutologousGraft vs Host DiseaseHematopoietic Stem Cell TransplantationBone Marrow CellsTransplantation ConditioningLiver TransplantationWhole-Body IrradiationTransplantation ChimeraGraft SurvivalTissue DonorsKidney TransplantationLeukemiaTransplantation, IsogeneicAnemia, AplasticStem Cell TransplantationBusulfanHistocompatibility TestingHistocompatibilityHematologic NeoplasmsRecurrenceTreatment OutcomeGraft RejectionHeart TransplantationHematopoietic Stem CellsTransplantation ImmunologyImmunosuppressive AgentsBone Marrow PurgingCyclophosphamideRemission InductionLung TransplantationBone and BonesCombined Modality TherapyLeukemia, Myeloid, AcuteLeukemia, Myelogenous, Chronic, BCR-ABL PositiveGraft vs Tumor EffectTime FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaImmunosuppressionMice, Inbred C57BLLymphocyte DepletionSurvival AnalysisAcute DiseaseRetrospective StudiesOrgan TransplantationHepatic Veno-Occlusive DiseaseHematopoiesisPeripheral Blood Stem Cell TransplantationBone Marrow DiseasesLeukemia, MyeloidT-LymphocytesRadiation ChimeraLymphoma, Non-HodgkinHLA AntigensCyclosporineGraft vs Leukemia EffectMyelodysplastic SyndromesMultiple MyelomaSurvival RateGraft vs Host ReactionLymphocyte TransfusionCord Blood Stem Cell TransplantationGranulocyte Colony-Stimulating FactorMelphalanCell TransplantationIslets of Langerhans TransplantationNuclear FamilyAntineoplastic Combined Chemotherapy ProtocolsLeukocyte TransfusionBone Marrow ExaminationPancreas TransplantationDisease-Free SurvivalHematopoietic Stem Cell MobilizationFollow-Up StudiesTransplantationAntigens, CD34Cytomegalovirus InfectionsChimeraSevere Combined ImmunodeficiencyAspergillus nidulansActuarial AnalysisBone Marrow NeoplasmsHematologic DiseasesColony-Forming Units AssayLymphomaSkin TransplantationMice, Inbred BALB CTransplantation ToleranceSalvage TherapyLiving DonorsCarmustineHodgkin DiseasePrognosisCytarabineCell DifferentiationSpleenVidarabineLife Tables